Search This Blog

Tuesday, August 6, 2019

BioCryst Pharmaceuticals EPS misses by $0.03, misses on revenue

BioCryst Pharmaceuticals (NASDAQ:BCRX): Q2 GAAP EPS of -$0.34 misses by $0.03.
Revenue of $1.45M (-88.4% Y/Y) misses by $0.57M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)